What are the indications, dosing, contraindications, and side effects of topical calcipotriene for plaque psoriasis?

Topical Calcipotriene for Plaque Psoriasis

Calcipotriene is a first-line topical vitamin D analogue indicated for mild to moderate plaque psoriasis in adults, with long-term use up to 52 weeks strongly recommended, and is most effective when combined with betamethasone dipropionate. 1, 2

Indications

Calcipotriene is FDA-approved specifically for plaque psoriasis in adults 2. The 2021 AAD-NPF guidelines provide Grade A recommendations for:

• Body psoriasis: Long-term use up to 52 weeks for mild to moderate disease 1
• Scalp psoriasis: Calcipotriene foam or calcipotriene/betamethasone dipropionate gel for 4-12 weeks 1
• Facial psoriasis: Calcipotriene combined with hydrocortisone for 8 weeks (Grade B recommendation) 1
• Nail psoriasis: Combined with betamethasone dipropionate to reduce thickness, hyperkeratosis, and onycholysis 1

Note that efficacy becomes apparent at 8 weeks, not 4 weeks, so patients should be counseled about this timeline 1.

Dosing

Apply calcipotriene 0.005% ointment/cream/foam twice daily, with a maximum weekly dose of 100 grams 3. Key dosing considerations:

• Monotherapy: Twice daily application
• Combination with betamethasone dipropionate 0.064%: Once or twice daily achieves 69-74% clear/almost clear status at 52 weeks 1
• Alternating regimens (Grade B):
  • Vitamin D analogues twice daily on weekdays + high-potency corticosteroids twice daily on weekends 1
  • Morning corticosteroid + evening vitamin D analogue 1

Contraindications

Per FDA labeling, calcipotriene is absolutely contraindicated in 2:

• Hypersensitivity to any component
• Hypercalcemia or evidence of vitamin D toxicity
• Facial application (contraindicated per FDA label, though guidelines support facial use when combined with hydrocortisone)

Side Effects and Safety Profile

Calcipotriene is remarkably safe with minimal systemic effects. The most common adverse events are:

Local Effects (Most Common)

• Lesional/perilesional irritation (~20% of cases) 4
• Face and scalp irritation
• Transient worsening of psoriasis
• Contact dermatitis (rare) 4

Systemic Effects (Extremely Rare)

• Hypercalcemia/hypercalciuria: Only reported when exceeding 100g/week 5
• In an 8-week study with up to 120g/week, no adverse effects on calcium or bone metabolism were observed 6
• The 52-week combination study showed no serious adverse events, striae, or HPA axis suppression 1

Approximately 6% of applied dose is absorbed systemically when applied to psoriatic plaques, with rapid metabolism to inactive metabolites within 24 hours 2.

Critical Drug Interactions and Pitfalls

Avoid These Combinations:

• Salicylic acid: The acidic pH inactivates calcipotriene—never use simultaneously 1
• UVA phototherapy before application: UVA radiation decreases calcipotriene concentration 1

Phototherapy Timing:

Always apply calcipotriene AFTER phototherapy, not before, to avoid:

• Inactivation by UVA radiation
• Blocking of UVB penetration (thick layers increase minimal erythema dose) 1

Comparative Efficacy

The evidence hierarchy shows:

1. Calcipotriene + betamethasone dipropionate > betamethasone alone > calcipotriene alone for 3-52 weeks 1
2. Ultrapotent/potent corticosteroids > calcipotriene monotherapy for 3-8 weeks 1
3. Calcipotriene > coal tar, salicylic acid but less effective than LCD 15% solution 1

The combination therapy achieves superior outcomes: 69-74% clear/almost clear versus 27% with vehicle at 52 weeks (P<0.001) 1.

Practical Treatment Algorithm

For new patients with mild-to-moderate plaque psoriasis:

1. Start with calcipotriene/betamethasone dipropionate combination once or twice daily (Grade A) 1
2. Continue up to 52 weeks on an as-needed basis with regular monitoring 7
3. For scalp involvement: Use foam or gel formulation for 4-12 weeks 1
4. For facial involvement: Switch to calcipotriene + hydrocortisone (not betamethasone) for 8 weeks 1
5. Set specific treatment goals at initiation to determine when to transition to maintenance 7

For maintenance: Consider alternating regimens (vitamin D weekdays/corticosteroid weekends) to minimize corticosteroid exposure while maintaining efficacy 1.